Masashi Yabuki

723 total citations
36 papers, 574 citations indexed

About

Masashi Yabuki is a scholar working on Oncology, Pharmacology and Computational Theory and Mathematics. According to data from OpenAlex, Masashi Yabuki has authored 36 papers receiving a total of 574 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Oncology, 15 papers in Pharmacology and 6 papers in Computational Theory and Mathematics. Recurrent topics in Masashi Yabuki's work include Drug Transport and Resistance Mechanisms (16 papers), Pharmacogenetics and Drug Metabolism (15 papers) and Computational Drug Discovery Methods (6 papers). Masashi Yabuki is often cited by papers focused on Drug Transport and Resistance Mechanisms (16 papers), Pharmacogenetics and Drug Metabolism (15 papers) and Computational Drug Discovery Methods (6 papers). Masashi Yabuki collaborates with scholars based in Japan, France and United Kingdom. Masashi Yabuki's co-authors include Setsuko Komuro, Takanori Hashizume, Kimihiko Sato, Masashi Mise, Toru Usui, Atsushi Kitamura, Tetsuya Nakagawa, Yasuyuki Mizuki, Iwao Nakatsuka and Takao Watanabe and has published in prestigious journals such as Chemosphere, Toxicology and Applied Pharmacology and Analytical and Bioanalytical Chemistry.

In The Last Decade

Masashi Yabuki

36 papers receiving 543 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Masashi Yabuki Japan 13 250 232 155 73 62 36 574
Setsuko Komuro Japan 13 226 0.9× 194 0.8× 134 0.9× 62 0.8× 43 0.7× 34 511
Daniel R. Mudra United States 11 270 1.1× 200 0.9× 217 1.4× 49 0.7× 37 0.6× 18 647
Mark Niosi United States 13 209 0.8× 238 1.0× 172 1.1× 97 1.3× 56 0.9× 22 542
Marc Bertrand France 15 310 1.2× 250 1.1× 301 1.9× 57 0.8× 57 0.9× 25 838
Philip Worboys United Kingdom 13 228 0.9× 168 0.7× 143 0.9× 61 0.8× 41 0.7× 14 558
Tsutomu Yoshimura Japan 13 171 0.7× 183 0.8× 205 1.3× 88 1.2× 25 0.4× 28 594
Anna Nordmark Sweden 15 247 1.0× 192 0.8× 137 0.9× 138 1.9× 49 0.8× 22 733
Abu Jafar Md. Sadeque United States 12 263 1.1× 137 0.6× 163 1.1× 98 1.3× 33 0.5× 21 535
Ken‐ichi Nunoya Japan 15 336 1.3× 254 1.1× 250 1.6× 100 1.4× 33 0.5× 23 649
Soraya Madani United States 6 291 1.2× 153 0.7× 86 0.6× 38 0.5× 43 0.7× 8 534

Countries citing papers authored by Masashi Yabuki

Since Specialization
Citations

This map shows the geographic impact of Masashi Yabuki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Masashi Yabuki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Masashi Yabuki more than expected).

Fields of papers citing papers by Masashi Yabuki

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Masashi Yabuki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Masashi Yabuki. The network helps show where Masashi Yabuki may publish in the future.

Co-authorship network of co-authors of Masashi Yabuki

This figure shows the co-authorship network connecting the top 25 collaborators of Masashi Yabuki. A scholar is included among the top collaborators of Masashi Yabuki based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Masashi Yabuki. Masashi Yabuki is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Watanabe, Masaki, Takao Watanabe, Masashi Yabuki, & Ikumi Tamai. (2015). Dehydroepiandrosterone sulfate, a useful endogenous probe for evaluation of drug–drug interaction on hepatic organic anion transporting polypeptide (OATP) in cynomolgus monkeys. Drug Metabolism and Pharmacokinetics. 30(2). 198–204. 27 indexed citations
2.
Nishizato, Yohei, et al.. (2014). Translational research into species differences of endocrine toxicity via steroidogenesis inhibition by SMP-028 — For human safety in clinical study. Toxicology and Applied Pharmacology. 276(3). 213–219. 2 indexed citations
3.
Nakagawa, Tetsuya, et al.. (2013). Significance of Reductive Metabolism in Human Intestine and Quantitative Prediction of Intestinal First-Pass Metabolism by Cytosolic Reductive Enzymes. Drug Metabolism and Disposition. 41(5). 1104–1111. 11 indexed citations
4.
5.
Inoue, Tomoko, Masaaki Tagawa, Yuriko Ogawa, et al.. (2012). Blonanserin, a novel atypical antipsychotic agent not actively transported as substrate by P-glycoprotein. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 39(1). 156–162. 17 indexed citations
6.
Yabuki, Masashi, et al.. (2011). Pharmacokinetics Characterization of Liposomal Amphotericin B: Investigation of Clearance Process and Drug Interaction Potential. Arzneimittelforschung. 59(9). 461–470. 7 indexed citations
7.
Kitamura, Atsushi, et al.. (2011). Liver uptake of Biguanides in rats. Biomedicine & Pharmacotherapy. 65(6). 451–455. 9 indexed citations
8.
Sato, Kimihiko, et al.. (2011). Prediction of the Intestinal First-pass Metabolism of CYP3A and UGT Substrates in Humans from in vitro Data. Drug Metabolism and Pharmacokinetics. 26(6). 592–601. 49 indexed citations
9.
Sato, Kimihiko, et al.. (2011). Species Differences in Intestinal Metabolic Activities of Cytochrome P450 isoforms between Cynomolgus Monkeys and Humans. Drug Metabolism and Pharmacokinetics. 26(3). 300–306. 24 indexed citations
10.
Sato, Kimihiko, et al.. (2010). Prediction of the Intestinal First-Pass Metabolism of CYP3A Substrates in Humans Using Cynomolgus Monkeys. Drug Metabolism and Disposition. 38(11). 1967–1975. 26 indexed citations
11.
Kitamura, Atsushi, et al.. (2009). A comparison of uptake of metformin and phenformin mediated by hOCT1 in human hepatocytes. Biopharmaceutics & Drug Disposition. 30(8). 476–484. 47 indexed citations
12.
Nishizato, Yohei, et al.. (2009). Development of relevant assay system to identify steroidogenic enzyme inhibitors. Toxicology in Vitro. 24(2). 677–685. 5 indexed citations
13.
Mizuno, Yoshiko, et al.. (2007). Identification of CYP3A4 as the primary cytochrome P450 responsible for the metabolism of tandospirone by human liver microsomes. European Journal of Drug Metabolism and Pharmacokinetics. 32(4). 233–240. 7 indexed citations
14.
15.
Yabuki, Masashi, et al.. (2005). Characterization of the enzymes involved in thein vitrometabolism of amrubicin hydrochloride. Xenobiotica. 35(12). 1121–1133. 27 indexed citations
16.
Yabuki, Masashi, et al.. (2000). Local Thrombus Formation in the Site of Intravenous Injection of Chlorpromazine. Possible Colloid-Osmotic Lysis of the Local Endothelial Cells.. Biological and Pharmaceutical Bulletin. 23(8). 957–961. 4 indexed citations
17.
Yabuki, Masashi, Shoji Saito, Tomoyuki Watanabe, et al.. (1996). Research to develop a predicting system of mammalian subacute toxicity (3) construction of a predictive toxicokinetics model. Chemosphere. 33(12). 2441–2468. 6 indexed citations
18.
Watanabe, Tomoyuki, Naohiko Isobe, Hiroshi Nishimura, et al.. (1996). A research to develop a predicting system of mammalian subacute toxicity (2) single dose detailed toxicity studies. Chemosphere. 32(5). 999–1019. 3 indexed citations
19.
Yabuki, Masashi, et al.. (1993). Absorption, Distribution and Excretion of SM-10888 in Rats.. Drug Metabolism and Pharmacokinetics. 8(6). 1169–1179. 1 indexed citations
20.
Arano, Yasushi, et al.. (1990). Stable and lipophilic technetium-99m dithiosemicarbazone complexes with 5-6-5 membered chelate ring structure.. Chemical and Pharmaceutical Bulletin. 38(11). 3099–3101. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Setsuko Komuro Breakdown of academic impact, for papers by Daniel R. Mudra Breakdown of academic impact, for papers by Mark Niosi Breakdown of academic impact, for papers by Marc Bertrand Breakdown of academic impact, for papers by Philip Worboys Breakdown of academic impact, for papers by Tsutomu Yoshimura Breakdown of academic impact, for papers by Anna Nordmark Breakdown of academic impact, for papers by Abu Jafar Md. Sadeque Breakdown of academic impact, for papers by Ken‐ichi Nunoya Breakdown of academic impact, for papers by Soraya Madani
Rankless by CCL
2026